YAKAWLANG, BAMIYAN PROVINCE, AFGHANISTAN - NOVEMBER 16, 2003. The MSf team prepare to leave the compound in Yakawlang to drive to the Dagah clinic, an hour drive away. MSf has been operating in Afghanistan for over 20 years. The main challenge to provide healthcare in the remote part of the country is isolation and security.
Browse the latest stories and reports on MSF from various media outlets.
The medical aid group—Doctors without Borders—warns that drug-resistant tuberculosis has become a global threat. It says despite the growing number of cases, there are no effective treatments. View external media.
The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.
From Sarah Boseley's Global Health Blog: Multi-drug resistant tuberculosis is on on the rise and hard to cure. Médecins Sans Frontières wants people with the disease to blog about it, to find out what they really need.
No doubt strides have been made in giving more people access to anti-retroviral drugs. But will the progress continue? Jim Clancy put that question to Emi Maclean, Director of the Doctors Without Borders Access Campaign.